BioSpace News Archive

The registered nurses at NVMC in Ayer, who are represented by the MNA, have filed unfair labor practice charges at the U.S. National Labor Relations Board (NLRB) against the Dallas-based for profit health care corporation after it issued a threat to close the hospital unless the nurses stopped attempting to bargain and accept Steward’s “final” offer.

Trusted network of PT practices across the U.S. offers #FightTheFall lifesaving risk assessment

Second year medical students with an established track record of community leadership, superior communication skills and demonstrated interest in advancing knowledge are recognized with the Canadian Medical Hall of Fame Award.

The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.07 per share.

TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced that it has surpassed $140,000 in funds raised for the V Foundation for Cancer Research thus far in 2019.

Epredia, a global leader in precision cancer diagnostics, has today announced that it will be attending the 31st European Congress of Pathology (ECP) later this week.

Kaiser Permanente, the nation’s largest nonprofit, integrated health care system, has received a U.S. Environmental Protection Agency 2019 Green Power Leadership Award in recognition of its use of renewable sources of energy to power its 39 hospitals and more than 700 medical offices.

Koneksa Health today announced a poster presentation of a study expanding initial findings that real-world data from activity trackers can predict hospitalization risk for patients having chemoradiotherapy better than traditional clinical assessments like performance status.

SymphonyRM, Healthcare’s Next Best Action Company, today announced that Intermountain Healthcare, a Utah-based not-for-profit integrated healthcare delivery network, is expanding its use of SymphonyRM’s HealthOS Platform to provide prioritized, personalized, and proactive patient engagement for their new Kidney Services organization.

GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced that its board of directors has appointed Pascal Prigent, GENFIT’s Executive Vice President of Marketing and Commercial Development, as Chief Executive Officer, following the recommendation of Jean-François Mouney, who will remain Chairman of the Board.